Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tilarginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 known ✓ | P29475 | 10/20 | 0.69 |
| ▸ | NOS2 known ✓ | P35228 | 9/20 | 0.69 |
| ▸ | NOS3 known ✓ | P29474 | 6/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | GLA | P06280 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.68 |
| ▸ | APEX1 | P27695 | 1/20 | 0.68 |
| ▸ | DDAH1 | O94760 | 5/20 | 0.65 |
| ▸ | THPO | P40225 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1736695 | 0.86 | NOS2 (0.68) | NOS1NOS2NOS3CYP2C19MEN1 | |
| SCHEMBL1736698 | 0.86 | NOS2 (0.68) | NOS1NOS2NOS3CYP2C19MEN1 | |
| SCHEMBL29824834 | 0.86 | NOS2 (0.68) | NOS1NOS2NOS3CYP2C19MEN1 | |
| SCHEMBL13484056 | 0.86 | NOS2 (0.64) | NOS1NOS2NOS3CYP2C19MEN1 | |
| SCHEMBL13484051 | 0.86 | NOS2 (0.64) | NOS1NOS2NOS3CYP2C19MEN1 | |
| Acetic Acid SCHEMBL29386173 | 0.85 | NOS2 (0.68) | NOS1NOS2NOS3CYP2C19MEN1 | |
| SCHEMBL29364827 | 0.83 | NOS2 (0.64) | NOS1NOS2NOS3CYP2C19MEN1 | |
| L-Nio SCHEMBL15944942 | 0.81 | NOS2 (1.00) | NOS1NOS2NOS3CYP2C19MEN1 | |
| Arginine SCHEMBL43261 | 0.81 | NOS2 (1.00) | NOS1NOS2NOS3CYP2C19MEN1 | |
| Arginine SCHEMBL288835 | 0.81 | NOS2 (1.00) | NOS1NOS2NOS3CYP2C19MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11872262-B2 | Means and methods for treating bacterial infections | VIB VZW (BE) | 2024-01-16 | — | — | US | disclosed |
| US-11872262-B2 | Means and methods for treating bacterial infections | VIB VZW (BE) | 2024-01-16 | — | — | US | disclosed |
| US-20210077563-A1 | Means and Methods for Treating Bacterial Infections | VIB VZW (BE) | 2021-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210077563-A1 | Means and Methods for Treating Bacterial Infections | VIP, MMP8, SLC11A2 | NOS1 288/4885NOS2 209/4885NOS3 226/4885 |
| US-11872262-B2 | Means and methods for treating bacterial infections | VIP, MMP8, SLC11A2 | NOS1 288/4885NOS2 209/4885NOS3 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.